Skip to content

Nxstage Pureflow Solution

by NxStage Medical, Inc. 2 variants

510(k) K033386

Nxstage Pureflow Solution is a medical device (FDA Class II; FDA product code KPO, Dialysate Concentrate For Hemodialysis (Liquid Or Powder)) made by NxStage Medical, Inc., cleared under FDA 510(k) K033386 on 26 Nov 2003, active as of 9 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 9 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 9 Oct 2026.

Regulatory status

as of registry sync 9 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK033386 Date26 Nov 2003ClearedStatusActive

Official records

From the FDA record

Received by the FDA
23 Oct 2003
FDA decision
26 Nov 2003 (Substantially Equivalent)
FDA review time
34 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K033386 (openFDA), as read on 9 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KPO
Device class
Class II
Regulation
21 CFR Part 876.5820
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).

Other devices from NxStage Medical, Inc.

See all devices from NxStage Medical, Inc. →